Abstract
A New Zealand smoking cessation study that compared 25 days of treatment with the plant‐based alkaloid cytisine vs. 8 weeks of nicotine replacement therapy found better abstinence outcomes with cytisine. The partial agonist of nicotinic acetylcholine receptors exceeded the expectations of researchers, who had hypothesized that cytisine would be at least as effective as nicotine replacement therapy in helping smokers to quit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
